Peginterferon alfa-2b Subcutaneous and Myelosuppression
Result of checking the interaction of drug Peginterferon alfa-2b Subcutaneous and disease Myelosuppression for safety when used together.
When checking interaction based on authoritative sources Drugs.com, Rxlist.com, Webmd.com, Medscape.com there are contraindications or side effects that may cause harm or increase the negative effect from drug use in presence of concomitant diseases.
Consumer:Interferons (alfa and gamma) induce a dose-dependent, generally mild, myelosuppression. Leukopenia is the primary manifestation. Thrombocytopenia and anemia occur less frequently. Therapy with interferons (alfa and gamma) should be administered cautiously to patients with bone marrow suppression. Clinical monitoring of hematopoietic function is recommended.
- "Product Information. Intron A (interferon alfa-2b)." Schering Laboratories, Kenilworth, NJ.
- "Product Information. Infergen (interferon alfacon-1)." Amgen, Thousand Oaks, CA.
Generic Name: peginterferon alfa-2b
Brand Name: PegIntron, Sylatron, PegIntron Redipen
Synonyms: Peginterferon alfa-2b, Peginterferon Alfa-2b